References
1. Sakurai A., Yamazaki M., Suzuki S., Fukushima T., Imai T., Kikumori T., et al. Clinical features of insulinoma in patients with multiple endocrine neoplasia type 1: analysis of the database of the MEN Consortium of Japan. Endocr J. 2012; 59 (10): 859–66. DOI: https://doi.org/10.1507/endocrj. ej12-0173
2. de Herder W.W., Niederle B., Scoazec J.Y., Pauwels S., Kloppel G., Falconi M., et al.; Frascati Consensus Conference; European Neuroendocrine Tumor Society. Well-differentiated pancreatic tumor/carcinoma: insulinoma. Neuroendocrinology. 2006; 84 (3): 183–8. DOI: https://doi.org/10.1159/000098010
3. Giannis D., Moris D., Karachaliou G.S., Tsilimigras D.I., Karaolanis G., Papalampros A., et al. Insulinomas: from diagnosis to treatment. A review of the literature. J BUON. 2020; 25 (3): 1302–14.
4. Vaidakis D., Karoubalis J., Pappa T., Piaditis G., Zografos G.N. Pancreatic insulinoma: current issues and trends. Hepatobiliary Pancreat Dis Int. 2010; 9 (3): 234–41. PMID: 20525548.
5. Manusharova R.A., Cherkezov D.I. Insulinoma (clinical picture, diagnosis, treatment). Meditsinskiy sovet [Medical Council]. 2011; (1–2): 59–63. URL: https://cyberleninka.ru/article/n/insulinoma-klinika-diagnostika-i-lechenie (in Russian)
6. Nikfarjam M., Warshaw A.L., Axelrod L., Deshpande V., Thayer S.P., Ferrone C.R., et al. Improved contemporary surgical management of insulinomas: a 25-year experience at the Massachusetts General Hospital. Ann Surg. 2008; 247 (1): 165–72. DOI: https://doi.org/10.1097/SLA.0b013e31815792ed
7. Service F.J., McMahon M.M., O’Brien P.C., Ballard D.J. Functioning insulinoma – incidence, recurrence, and long-term survival of patients: a 60-year study. Mayo Clin Proc. 1991; 66 (7): 711–9. DOI: https://doi.org/10.1016/s0025-6196(12)62083-7
8. Service F.J., Dale A.J., Elveback L.R., Jiang N.S. Insulinoma: clinical and diagnostic features of 60 consecutive cases. Mayo Clin Proc. 1976; 51 (7): 417–29. PMID: 180358.
9. ASGE Standards of Practice Committee; Eloubeidi M.A., Decker G.A., Chandrasekhara V., Chathadi K.V., Early D.S., Evans J.A., et al. The role of endoscopy in the evaluation and management of patients with solid pancreatic neoplasia. Gastrointest Endosc. 2016; 83 (1): 17–28. DOI: https://doi.org/10.1016/j.gie.2015.09.009
10. Okabayashi T., Shima Y., Sumiyoshi T., Kozuki A., Ito S., Ogawa Y., et al. Diagnosis and management of insulinoma. World J Gastroenterol. 2013; 19 (6): 829–37. DOI: https://doi.org/10.3748/wjg. v19.i6.829
11. Su A.P., Ke N.W., Zhang Y., Liu X.B., Hu W.M., Tian B.L., et al. Is laparoscopic approach for pancreatic insulinomas safe? Results of a systematic review and meta-analysis. J Surg Res. 2014; 186 (1): 126–34. DOI: https://doi.org/10.1016/j.jss.2013.07.051
12. Murakami T., Yamashita T., Yabe D., Masui T., Teramoto Y., Minamiguchi S., et al. Insulinoma with a history of epilepsy: still a possible misleading factor in the early diagnosis of insulinoma. Intern Med. 2017; 56 (23): 3199–204. DOI: https://doi.org/10.2169/internalmedicine.8932-17
13. Hayashida R., Tsuchiya K., Sekine T., Momose T., Sato F., Sakurada M., et al. A clinical case of insulinoma presenting with postprandial hypoglycemia in a patient with a history of gastric bypass surgery. Intern Med. 2022; 61 (8): 1189–95. DOI: https://doi.org/10.2169/internalmedicine.7428-21
14. Nakajima R., Idesawa H., Sato D., Ito J., Ito K., Fujii M., et al. Continuous glucose monitoring in a patient with insulinoma presenting with unawareness of postprandial hypoglycemia. Endocrinol Diabetes Metab Case Rep. 2023; 2023 (3): 23-0056. DOI: https://doi.org/10.1530/EDM-23-0056
15. Suminaga K., Murakami T., Yabe D., Sone M., Sugawa T., Masui T., et al. Factory-calibrated continuous glucose monitoring and capillary blood glucose monitoring in a case with insulinoma: usefulness and possible pitfall under chronic hyperinsulinemic hypoglycemia. Endocr J. 2020; 67 (3): 361–6. DOI: https://doi.org/10.1507/endocrj. EJ19-0339
16. Sugawa T., Murakami T., Yabe D., Kashima R., Tatsumi M., Ooshima S., et al. Hypoglycemia unawareness in insulinoma revealed with flash glucose monitoring systems. Intern Med. 2018; 57 (23): 3407–12. DOI: https://doi.org/10.2169/internalmedicine.1173-18
17. Ma J., Huang X., Zhao J., Lu J., Lu W., Bao Y., et al. CGM for insulinoma screening: a prospective and observational case-control study. Endocr Relat Cancer. 2021; 28 (5): 291–300. DOI: https://doi.org/10.1530/ERC-20-0447